- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
LifeMD Inc (LFMD)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/19/2025: LFMD (3-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $9.25
1 Year Target Price $9.25
| 6 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 175.22% | Avg. Invested days 35 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 155.48M USD | Price to earnings Ratio - | 1Y Target Price 9.25 |
Price to earnings Ratio - | 1Y Target Price 9.25 | ||
Volume (30-day avg) 8 | Beta 1.36 | 52 Weeks Range 3.21 - 15.84 | Updated Date 12/21/2025 |
52 Weeks Range 3.21 - 15.84 | Updated Date 12/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.25 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.21% | Operating Margin (TTM) -3.27% |
Management Effectiveness
Return on Assets (TTM) -2.85% | Return on Equity (TTM) -2243.07% |
Valuation
Trailing PE - | Forward PE 14.73 | Enterprise Value 138459111 | Price to Sales(TTM) 0.62 |
Enterprise Value 138459111 | Price to Sales(TTM) 0.62 | ||
Enterprise Value to Revenue 0.55 | Enterprise Value to EBITDA 20.65 | Shares Outstanding 48135885 | Shares Floating 39176353 |
Shares Outstanding 48135885 | Shares Floating 39176353 | ||
Percent Insiders 15.03 | Percent Institutions 43 |
Upturn AI SWOT
LifeMD Inc

Company Overview
History and Background
LifeMD, Inc. (formerly eHealth-Services, Inc.) was founded in 2014. The company has undergone significant transformation, rebranding to LifeMD in 2020 and focusing on a direct-to-consumer telehealth model. Key milestones include the expansion of its digital health platform and strategic acquisitions aimed at broadening its service offerings and patient reach.
Core Business Areas
- Telehealth Platform: LifeMD operates a comprehensive telehealth platform that connects patients with licensed healthcare providers for virtual consultations, diagnoses, and treatment plans. This includes prescription management and chronic care services.
- Specialty Care: The company offers specialized care in areas such as weight management, men's health, women's health, dermatology, and mental health, leveraging its telehealth infrastructure.
- Pharmacy Services: LifeMD partners with pharmacies to facilitate the fulfillment of prescriptions generated through its telehealth services, offering convenience to patients.
Leadership and Structure
LifeMD is led by a management team responsible for strategic direction and operational execution. The company is structured to support its telehealth services, with dedicated teams for clinical operations, technology development, marketing, and patient support.
Top Products and Market Share
Key Offerings
- Weight Management Program: A comprehensive telehealth program focused on weight loss, including consultations with healthcare providers, personalized treatment plans, and prescription medication when appropriate. Competitors include companies like Ro, Hims & Hers, and numerous traditional weight loss clinics and programs.
- Dermatology Services: Virtual dermatology consultations for diagnosis and treatment of various skin conditions, including prescription services for topical and oral medications. Competitors include Apostrophe, SkyMD, and other specialized telehealth dermatology providers.
- Men's Health Services: Telehealth services addressing common men's health issues such as erectile dysfunction, hair loss, and testosterone replacement therapy. Key competitors include Hims, Ro, and Lemonaid Health.
Market Dynamics
Industry Overview
The telehealth and digital health industry is experiencing rapid growth, driven by increasing patient demand for convenient, accessible, and affordable healthcare solutions. Factors such as technological advancements, favorable regulatory environments, and the ongoing need for chronic disease management contribute to this expansion. The market is characterized by increasing competition from both established healthcare providers and innovative tech companies.
Positioning
LifeMD is positioned as a direct-to-consumer telehealth provider offering a broad range of specialized care services through its digital platform. Its competitive advantages lie in its integrated model, encompassing virtual consultations, prescription fulfillment, and a focus on chronic care management. The company aims to differentiate itself through its brand, patient experience, and the breadth of its service offerings.
Total Addressable Market (TAM)
The global digital health market is projected to reach hundreds of billions of dollars in the coming years. LifeMD is positioned to capture a portion of this TAM by focusing on specific chronic and specialized care segments within the broader telehealth market. Its success depends on its ability to scale its patient base, expand its service offerings, and compete effectively against a growing number of players.
Upturn SWOT Analysis
Strengths
- Established telehealth platform with a focus on specialized care.
- Integrated model including virtual consultations and pharmacy services.
- Brand recognition within the direct-to-consumer telehealth space.
- Ability to scale operations through technology.
Weaknesses
- Reliance on third-party pharmacies for prescription fulfillment.
- Potential for increased regulatory scrutiny in the telehealth space.
- Brand perception and trust-building challenges in a competitive market.
- High marketing and customer acquisition costs.
Opportunities
- Expansion into new therapeutic areas and specialized services.
- Partnerships with employers, insurers, and healthcare systems.
- Leveraging data analytics for personalized patient care and operational efficiency.
- International market expansion.
Threats
- Intensifying competition from both established players and new entrants.
- Changes in telehealth regulations and reimbursement policies.
- Data privacy and cybersecurity risks.
- Economic downturns affecting consumer spending on healthcare services.
Competitors and Market Share
Key Competitors
- Ro (RO)
- Hims & Hers Health, Inc. (HIMS)
- Teladoc Health, Inc. (TDOC)
- Amwell Corporation (AMWL)
- MDconnect (Private)
Competitive Landscape
LifeMD faces intense competition from both pure-play telehealth providers and established healthcare entities venturing into digital health. Its advantages lie in its specialized care focus and integrated model. However, it contends with larger players with greater resources, brand recognition, and established patient networks. Differentiating its service quality and patient experience is crucial for maintaining and growing its market share.
Growth Trajectory and Initiatives
Historical Growth: LifeMD has experienced substantial historical growth, primarily driven by its expansion in the direct-to-consumer telehealth market and strategic acquisitions. This growth has been characterized by increasing patient acquisition and revenue figures.
Future Projections: Future growth projections for LifeMD are typically based on analyst estimates that consider market trends, company-specific strategies, and competitive pressures. These projections often anticipate continued expansion in existing service lines and the introduction of new offerings.
Recent Initiatives: Recent initiatives may include platform enhancements, expansion into new therapeutic areas, marketing campaigns to increase brand awareness, and partnerships aimed at broadening its reach and service capabilities.
Summary
LifeMD Inc. operates within the rapidly expanding telehealth sector, offering specialized care through its digital platform. The company has demonstrated strong revenue growth and has a clear strategic focus on expanding its service offerings and patient reach. However, it faces significant competition, high customer acquisition costs, and regulatory uncertainties, which are key areas to monitor for its future success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company investor relations websites
- Financial news outlets
- Market research reports
- SEC filings (e.g., 10-K, 10-Q)
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute investment advice. Financial data and market share figures are estimates and may vary. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About LifeMD Inc
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2001-01-02 | Chairman & CEO Mr. Justin Schreiber | ||
Sector Healthcare | Industry Health Information Services | Full time employees 304 | Website https://lifemd.com |
Full time employees 304 | Website https://lifemd.com | ||
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; and Cleared which provides personalized treatments for allergy, asthma and immunology. It also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. Further, it offers GLP-1 for weight management and in-home health monitoring devices. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

